Miracle Mile Advisors’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
84,008
-17,035
-17% -$367K 0.02% 346
2026
Q2
$2.2M Buy
101,043
+9,664
+11% +$211K 0.03% 304
2026
Q1
$2M Buy
91,379
+32,469
+55% +$716K 0.03% 304
2025
Q4
$1.3M Buy
58,910
+7,178
+14% +$159K 0.02% 372
2025
Q3
$1.15M Sell
51,732
-133
-0.3% -$2.93K 0.02% 390

Other funds holding IBDV

Miracle Mile Advisors's IBDV Position: Q3 2026 in Review

Miracle Mile Advisors reduced its iShares iBonds Dec 2030 Term Corporate ETF (IBDV) stake by 17% in Q3 2026, selling an estimated $367K and leaving 84,008 shares worth $1.78M. The position accounts for 0.02% of the portfolio, ranked #346.

Miracle Mile Advisors first reported a position in IBDV in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.2M in Q2 2026. 359 funds tracked by Wall St. Rank hold IBDV as of Q3 2026.

  • Miracle Mile Advisors held 84,008 shares of iShares iBonds Dec 2030 Term Corporate ETF worth $1.78M as of Q3 2026.
  • Miracle Mile Advisors sold 17,035 iShares iBonds Dec 2030 Term Corporate ETF shares in Q3 2026, an estimated $367K.
  • iShares iBonds Dec 2030 Term Corporate ETF made up 0.02% of Miracle Mile Advisors's portfolio in Q3 2026, its #346 holding.
  • Miracle Mile Advisors first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q3 2025 and has held it in 5 quarters since.
  • Miracle Mile Advisors's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $2.2M in Q2 2026.
  • 359 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q3 2026.

Based on Miracle Mile Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.